Skip to content

Clinical trials

Phase 2 Fallopian Tube Neoplasms trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Fallopian Tube Neoplasms Phase: Phase 2 Clear all

293 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20005
20015
20026
20039
20049
20058
200622
200716
200811
20099
201021
201110
201212
20139
20146
201510
201613
201711
201810
20199
20204
202111
20229
202315
202410
202510
20266

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed157
Terminated37
Recruiting30
Active, not recruiting26
Unknown status25
Withdrawn10
Not yet recruiting8

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
National Cancer Institute (NCI)39
Gynecologic Oncology Group14
M.D. Anderson Cancer Center11
Dana-Farber Cancer Institute10
Memorial Sloan Kettering Cancer Center9
Mayo Clinic6
AbbVie5
Roswell Park Cancer Institute5
University Health Network, Toronto5
AGO Study Group4

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Fallopian Tube Neoplasms293
Ovarian Neoplasms246
Carcinoma, Ovarian Epithelial106
Endometrial Neoplasms19
Neoplasms18
Peritoneal Neoplasms14
Uterine Cervical Neoplasms14
Recurrence13
Brenner Tumor11
Breast Neoplasms9

Trials

Showing 26 to 50 of 293. Each trial links to its page on Pharma Observatory.

193 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.